Visnafylline

This classification denotes a bronchodilator with the molecular formula C18H22NO5.C7H7N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GB901PL1KW, chemically known as (2-((9-methoxy-7-methyl-5-oxo-5h-furo(3,2-g)(1)benzopyran-4-yl)oxy)ethyl)trimethylammonium theophylline derivate but generally known as visnafylline, which bears US NIH Compound Identifier 3084273. European Medicines Agency schedules Visnafylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00084MIG. The term VISNAFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). VISNAFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule visnafylline under HS 29395900 and SITC 54145. As of Q4 2014, VISNAFYLLINE remains the US FDA Preferred Term for this commodity. Visnafylline bears US NLM identifiers UMLS ID C2700253 and NCI Concept Code C74217. SMILES: O(CC[N](C)(C)C)C1C2C(OCC2)C(OC)C2OC(CC(=O)C12)C.O=C1N(C2NCNC2C(O)N1C)C.